This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Adenomyosis
and you are
between 20 and 45
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Objective: To investigate the effects of levonorgestrel-releasing intrauterine system (LNG-IUS) for symptomatic adenomyosis. Methods: From December, 2006 to December, 2014, symptomatic patients of adenomyosis diagnosed (with dysmenorrhea and/or menorrhea) by transvaginal ultrasound in outpatient or inpatient clinics of Peking Union Medical College Hospital were given the treatment of LNG-IUS. Before and after placement of LNG-IUS, during each following period, all the parameters were recorded prospectively, including carrying status of IUS, symptoms and scores of dysmenorrhea, menstruation scores, biochemical indicators, physical parameters, menstruation patterns and adverse effects. Primary outcome measures: symptoms and scores of dysmenorrhea and menorrhea Second outcome measures: carrying status of IUS

Provided treatments

  • Procedure: Placement of levonorgestrel-releasing intrauterine system
Tris trial is registered with FDA with number: NCT03027648. The sponsor of the trial is Peking Union Medical College Hospital and it is looking for 1100 volunteers for the current phase.
Official trial title:
Cohort Study of Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis